Identification of potential predictive biomarkers during JAK-inhibitor therapies in rheumatoid arthritis

János Rózsa, Dóra Csige, Monika Bodoki, Zsófia Hagymási-Szabó, Ferenc Tóth, Szilvia Szamosi, Ágnes Horváth, Nóra Bodnár, Edit Végh, Sándor Szántó, Gabriella Szűcs, Zsófia Pethő, Zsuzsanna Gyetkó, Levente Bodoki, János Kádas, Zoltán Szekanecz, Szilárd Póliska · 2025

Read Identification of potential predictive biomarkers during JAK-inhibitor therapies in rheumatoid arthritis by János Rózsa, Dóra Csige, Monika Bodoki, Zsófia Hagymási-Szabó, Ferenc Tóth, Szilvia Szamosi, Ágnes Horváth, Nóra Bodnár, Edit Végh, Sándor Szántó, Gabriella Szűcs, Zsófia Pethő, Zsuzsanna Gyetkó, Levente Bodoki, János Kádas, Zoltán Szekanecz, Szilárd Póliska (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12837950.txt.

Description

János Rózsa and co-authors hunt for blood signs that predict who will benefit from a class of arthritis drugs, in work from 2025. The drugs block signals that drive joint swelling. They help many patients with rheumatoid arthritis, but not all, and they cost a great deal.

The team took blood from 28 patients before treatment and again after six months on the drugs. They read gene activity in white blood cells at both times. Shifts in gene patterns may mark who responds well and who does not. Early signs like these could spare non-responders months of failed treatment. They could also save health systems money by guiding drug choice sooner.

Catalog record

CREATORJános Rózsa, Dóra Csige, Monika Bodoki, Zsófia Hagymási-Szabó, Ferenc Tóth, Szilvia Szamosi, Ágnes Horváth, Nóra Bodnár, Edit Végh, Sándor Szántó, Gabriella Szűcs, Zsófia Pethő, Zsuzsanna Gyetkó, Levente Bodoki, János Kádas, Zoltán Szekanecz, Szilárd Póliska
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE32 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12837950

Browse the full library · About the Tower of Babel